PCSS-O Upcoming Webinar: SCOPE of Pain: Safe and Competent Opioid Prescribing Education (Webinar 2 of 3) (AOAAM)

Prescribers’ Clinical Support System for Opioid Therapies (PCSS-O) is a three year grant funded by Substance Abuse and Mental Health Services Administration (SAMHSA),Center for Substance Abuse Treatment (CSAT). It is a collaborative project led by American Academy of Addiction Psychiatry (AAAP) with: American Dental Association (ADA), American Medical Association (AMA), American Osteopathic Academy of Addiction Medicine (AOAAM), American Psychiatric Association (APA), American Society for Pain Management Nursing (ASPMN), and International Nurses Society on Addictions (IntNSA). These organizations are providing training and education on the safe and effective prescribing of opioid medications in the treatment of pain and/or opioid addiction.

            
Webinar Information:

A webinar offered by American Osteopathic Academy of Addiction Medicine (AOAAM).

About the Webinar:
In order to receive credit, individuals must participate in all three webinars (September, October, and November either via webinar or recording). Instructions on how to obtain credit will be provided posted after our November 27th webinar.

SCOPE of Pain is a three-part educational program that will help you safely and competently manage your patients with chronic pain. Through the case of Mary Williams, a 42 year old with painful diabetic neuropathy and chronic low back pain, you'll learn how to: 1) decide on appropriateness of opioid analgesics; 2) assess for opioid misuse risk; 3) counsel patients about opioid safety, risks and benefits; 4) competently monitor patients prescribed opioids for benefit and harm; 5) make decisions on continuing or discontinuing opioid analgesics; 6) safely discontinue opioids when there is too little benefit or too much risk and harm.

This program is funded by an independent educational grant awarded by the manufacturers of extended-release (ER) and long-acting (LA) opioid analgesics, collectively known as the Risk Evaluation and Mitigation Strategy (REMS) Program Companies, or RPC. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the U.S. Food & Drug Administration (FDA).

Date: October 30, 2013

Speaker: Seddon Savage, MD, MS, FASAM 
Time: 12:00 pm – 1:00 pm ET
                                                                       
To Register: http://events.constantcontact.com/register/event?llr=c9shxsbab&oeidk=a07e833aq90fe2a79fb

Funding for this initiative was made possible (in part) by Prescribers’ Clinical Support System for Opioid Therapies (1H79TI023439) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.